$MDWD SEC Filings

Filed On	Filing
02 Sep 2026	Form 4: Rubinstein Samuel, Director Sold 525 shares ($6.68K) · Bought 525 shares ($6.63K)
28 Aug 2026	Form 4: Hess Shmuel, COO & Chief Commercial Officer Sold 1,865 shares ($24.2K) · Exercised 5,000 Stock Option (right to buy ordinary shares) · Sold 3,958 shares ($51.1K) · 1 more
28 Aug 2026	SCHEDULE 13G/A
28 Aug 2026	144
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	6-K
04 Jun 2026	Form 4: Shamir Nachum, Director Bought 6,000 shares ($84K)
02 Jun 2026	Form 4: Fox David Morton, Director Bought 3,537 shares ($49.9K)
01 Jun 2026	Form 4: Rubinstein Samuel, Director Bought 150 shares ($2.15K)
27 May 2026	6-K
15 May 2026	SCHEDULE 13G
06 May 2026	6-K
02 Apr 2026	6-K
30 Mar 2026	6-K
25 Mar 2026	Form 3: Driver Vickie Rae, Director Holds 1,910 shares of Ordinary shares
18 Mar 2026	Form 3: Luxenburg Kalfon Hana, Chief Financial Officer Holds 4,085 shares of Ordinary shares
18 Mar 2026	Form 3: Klinger Ety, Chief Medical Officer Holds 1,743 shares of Ordinary shares
18 Mar 2026	Form 3: Fox David Morton, Director Holds 18,746 shares of Ordinary shares
18 Mar 2026	Form 3: Ben Yaakov Aya, VP Clinical & Reg. Affairs Holds 432 shares of Ordinary shares
18 Mar 2026	Form 3: Meyer Yaron, EVP, GC & Corp. Secretary Holds 1,413 shares of Ordinary shares

Comments